An international panel of the foremost researchers on infectious disease and antimicrobials has formed new guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat deadly, drug-resistant bacteria.
Tufts University and Tufts Medical Center unite decades of experience and expertise in infectious disease research and clinical care with the Tufts Center for Integrated Management of Antimicrobial Resistance to more effectively address the rise and spread of multi-drug resistant organisms.
Antibiotics survival mechanism: UC San Diego researchers have discovered an unexpected mechanism that allows bacteria to defend themselves against antibiotics, a surprise finding that could lead to retooled drugs to treat infectious diseases.
Researchers at The Wistar Institute have created a drug candidate for cancers associated with Epstein-Barr Virus (EBV), the virus that causes infectious mononucleosis.
The products of wastewater treatment have been found to contain trace amounts of antibiotic resistant DNA. These products are often reintroduced to the environment and water supply, potentially resulting in the spread of antibiotic resistance.
U.S. Food and Drug Administration Approves New Drug that Could Bring Relief to Millions of People with Treatment-Resistant Depression
Each year, approximately 5 million patients in the United States receive treatment that includes the insertion of a medical device such as a catheter, which puts them at increased risk of potentially life-threatening infection. Researchers have found a strategy that greatly reduced both overall infection and infection with antibiotic-resistant bacteria in a group of these patients. The results of their study were published today in the online issue of The Lancet.
Neutrons used to study how an antibacterial peptide fights bacteria; decade-long study finds higher CO2 levels caused 30 percent more wood growth in U.S. trees; ultrasonic additive manufacturing to embed fiber optic sensors in heat- and radiation-resistant materials could yield safer reactors; ORNL analyzes “dark spots” where informal neighborhoods may lack power access; new Transportation Energy Data Book released.
Researchers at Indiana University have invented a new method to observe bacterial build cell walls in real time that could contribute to the search for new antibacterial drugs.
Scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified how prostate cancer transforms into a deadly treatment-resistant subtype following treatment with anti-androgen therapy. Their findings—which include the metabolic rewiring and the epigenetic alteration that drives this switch— reveal that an FDA-approved drug holds potential as a NEPC treatment. The research also uncovers new therapeutic avenues that could prevent this transformation from occurring. The study was published in Cancer Cell.
Grocery store aisles are stocked with products that promise to kill bacteria. However, new research from Washington University in St. Louis finds that a chemical that is supposed to kill bacteria is actually making them stronger and more capable of surviving antibiotic treatment.
Over-testing for urinary tract infections (UTIs) leads to unnecessary antibiotic use, which spreads antibiotic resistance. Infectious disease specialists at Washington University School of Medicine in St. Louis made changes to hospital procedures that cut urine tests by nearly half without compromising doctors’ abilities to detect UTIs.
With a $3.34M grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health Case Western Reserve University School of Medicine is conducting research that could help physicians better understand how bacteria such as B. multivorans resist antibiotics, potentially leading to improved treatments.
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into how germs adapt and behave at a level of detail never seen before.
A high proportion of multidrug-resistant tuberculosis (TB) cases can be cured in conflict-affected communities with molecular diagnostics, shorter treatment periods and socioeconomic incentives, according to the results of a large, long-term study in the Democratic Republic of Congo.
Even as hospitals try to cut back on prescribing powerful but risky antibiotics called fluoroquinolones, a new study shows that many patients still head home with prescriptions for the drugs -- increasing their risk of everything from "superbug" infections to torn tendons. In fact, the hospitals that are actively trying to reduce inpatient fluoroquinolone use were twice as likely to discharge patients with a new prescription for one of them.
A novel, synthetic DNA vaccine developed at The Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to become a global emerging viral threat.
We rely on antibiotics to treat bacterial infections, but the rise of antibiotic-resistant bacteria forces doctors and patients to contend with shifting treatment plans. Furthermore, current laboratory tests to determine what bacteria is causing a particular infection takes days to complete and can be too late for the patient. Mechanical engineers in Korea recently developed a microchip antibiotic testing platform that takes only six to seven hours to determine the appropriate medication.
A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.
. In an exhaustive search of microbes from more than 1,400 insects collected from diverse environments across North and South America, a UW-Madison research team found that insect-borne microbes often outperformed soil bacteria in stopping some of the most common and dangerous antibiotic-resistant pathogens.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right